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Abstract 
The innate immune system, acting as the first line of host defense, senses and adapts to 
foreign challenges through complex intracellular and intercellular signaling networks. 
Endotoxin tolerance and priming elicited by macrophages are classic examples of the 
complex adaptation of innate immune cells. Upon repetitive exposures to different doses 
of bacterial endotoxin (lipopolysaccharide) or other stimulants, macrophages show either 
suppressed or augmented inflammatory responses compared to a single exposure to the 
stimulant. Endotoxin tolerance and priming are critically involved in both immune 
homeostasis and the pathogenesis of diverse inflammatory diseases. However, the 
underlying molecular mechanisms are not well understood. By means of a computational 
search through the parameter space of a coarse-grained three-node network with a two-
stage Metropolis sampling approach, we enumerated all the network topologies that can 
generate priming or tolerance. We discovered three major mechanisms for priming 
(pathway synergy, suppressor deactivation, activator induction) and one for tolerance 
(inhibitor persistence). These results not only explain existing experimental observations, 
but also reveal intriguing test scenarios for future experimental studies to clarify 
mechanisms of endotoxin priming and tolerance.       
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Author Summary 
Inflammation is a fundamental response of animals to pathogen invasion. Among the first 
responders are macrophage cells, which identify and respond to multiple challenges. 
Their responses must be carefully regulated to kill invading pathogens without causing 
too much damage to host cells. Excessive activity of macrophages is associated with 
serious diseases like sclerosis and cancer. Macrophage responses are governed by a 
complex signaling network that receives cues, integrates information, implements 
appropriate responses and communicates with neighboring cells. This network must 
maintain a short-term memory of pathogen exposure. Endotoxin priming is an example. 
If macrophages are exposed to a small dose of bacterial toxins, they are primed to 
respond strongly to a second exposure to a large dose of toxin. Endotoxin tolerance, on 
the other hand, refers to the fact that macrophages are resistant to endotoxin challenges 
after a large dose pretreatment. The precise molecular mechanisms of both priming and 
tolerance are still poorly understood. Through computational systems biology, we have 
identified basic regulatory motifs for priming and for tolerance. Using information from 
databases and the literature, we have identified molecules that may contribute to priming 
and tolerance effects. Our methods are generally applicable to other types of cellular 
responses. 
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Introduction 
Innate immune cells such as macrophages and dendritic cells constitute the first layer of 
host defense. Like policemen constantly patrolling the streets for criminal activity, these 
cells are responsible for initiating the first attack against invading pathogens [1,2]. For 
example, using Toll-like receptor 4 (TLR4), macrophages recognize lipopolysaccharide 
(LPS, also called endotoxin), a pathogen-associated molecular pattern (PAMP) that is 
expressed on the outer membrane of gram-negative bacteria. Within hours of stimulation, 
hundreds of regulatory genes, kinases, cytokines, and chemokines are activated in 
sequential waves, leading to a profound inflammatory and anti-microbial response in 
macrophages [3]. Although effective levels of inflammation require potent cytokine 
production, excessive or prolonged expression can be detrimental, resulting in various 
immune diseases, such as autoimmunity, atherosclerosis, sepsis shock and cancers [3,4]. 
Owing to this double-edged nature of innate immunity, living organisms have evolved a 
highly complex signaling network to fine-tune the expression of cytokines [5]. A 
fundamental question in this field is what kinds of network topologies and dynamics in 
the signaling network ensure the appropriate expression of cytokines. This question is 
part of a larger current theme in systems biology of the design principles of biological 
networks. Are there small network motifs that serve as building blocks to perform 
complex “information processing” functions in biological signaling networks [6-12]? In 
this context, a systems and computational biology approach may greatly deepen our 
understanding in innate immunity [13-17]. 
Here we focus on the signaling motifs responsible for endotoxin priming and tolerance of 
macrophages. The interaction between host macrophages and bacterial endotoxin is 
arguably one of the most ancient and highly conserved phenomena in multi-cellular 
eukaryotic organisms [5]. Through TLR4, LPS activates MyD88-dependent and MyD88-
independent pathways, which eventually lead to the regulation of a number of 
downstream genes and pathways, including the mitogen-activated protein kinase 
(MAPK), phosphoinositide 3-kinase (PI3K), and nuclear factor κB (NFκB). The 
integration of these intracellular pathways leads to measured induction of pro-
inflammatory mediators. Intriguingly, the induction of inflammatory mediators is also 
finely controlled by the quantities and prior history of LPS challenges. The latter is 
physiologically relevant since cells are likely repetitively exposed to stimulants in their 
natural environment. For example, numerous in vitro studies have found that significant 
induction of cytokine TNF-α and IL-6 requires at least 10 ng/mL LPS in mouse 
peritoneal macrophages [18,19] and macrophage cell lines [20], and a high dose of LPS 
(100 ng/mL) is sufficient to trigger a catastrophic “cytokine storm”. Strikingly, however, 
the dose-response relationship can be reprogrammed by two successive treatments with 
LPS, to give either a reduced or an augmented expression of cytokines (Figure 1A). In 
vitro, preconditioning macrophages with a high dose (HD) of LPS (10−100 ng/mL) 
renders the cells much less responsive to a subsequent HD stimulation in terms of pro-
inflammatory cytokine expression. This phenomenon, known as “endotoxin tolerance” or 
“LPS tolerance” [21], is reported to last up to 3 weeks in vivo [22]. On the other hand, 
macrophages primed by a low dose (LD) of LPS (0.05−1 ng/mL) show an augmented 
production of cytokine in response to a subsequent HD  challenge, a phenomenon known 
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as “LPS priming” [18,19,23-25]. Both priming and tolerance are present in other cells of 
the innate immune system including monocytes and fibroblasts, and are highly conserved 
from mice to humans. Our own studies on murine macrophages show both effects (Figure 
1B).    
Endotoxin priming and tolerance may confer significant survival advantages to higher 
eukaryotes. Priming of innate immune cells may enable robust and expedient defense 
against invading pathogens, a mechanism crudely analogous to vaccination of the 
adaptive immune system. On the other hand, tolerance may promote proper homeostasis 
following robust innate immune responses. However, despite these survival advantages, 
endotoxin priming and tolerance are also closely associated with the pathogenesis of both 
chronic and acute human diseases. For example, despite the potential ability to limit pro-
inflammatory cytokine production, endotoxin tolerance is responsible for the induction of 
immunosuppression in patients with sepsis shock, and this suppression leads to increased 
incidence to secondary infections and mortality [22]. Endotoxin priming, on the other 
hand, reprograms macrophages to super-induction of proinflammatory cytokines. 
Increasing evidence relates this phenomenon to low-grade metabolic endotoxemia, where 
an elevated but physiological level of LPS in the host’s bloodstream results in a higher 
incidence of insulin resistance, diabetes and atherosclerosis [26-29]. Augmented IL-6 
expression has also been observed in human blood cells that were primed by LD and 
challenged by HD LPS [30]. 
Despite the significance and intense research efforts, molecular mechanisms responsible 
for endotoxin priming and tolerance are not well understood, apparently due to the 
complex nature of intracellular signaling networks. Tolerance has been attributed to the 
negative regulators at multiple levels of the TLR4 signaling pathway. These include 
signaling molecules (e.g. SHIP, ST2, induction of IRAK-M and suppression of IRAK-1), 
transcriptional modulators (e.g. ATF3, p50/p50 homodimers), soluble factors (e.g. IL-10 
and TGFβ), and gene-specific chromatin modifications [21,31-38]. These negative 
regulators are likely to work together to drive macrophages into a transient refractory 
state for cytokine expression after LPS pretreatment [33]. Molecular mechanisms for 
priming are rarely studied and even less well understood than tolerance. Early studies 
suggest that like endotoxin tolerance, both intra- and inter-cellular events may be 
involved in LPS priming [24]. Morrison and coworkers first revealed that LPS priming of 
cytokine TNF-α production is induced, at least in part, by a reprogrammed 
counterbalance between endogenous IL-10 and IL-12 in an autocrine fashion [19]. 
However, it is still elusive exactly how the change in two counteracting soluble secretory 
products can contribute to the priming effect, and whether LPS priming is exclusively an 
intercellular event or it takes place at both intra- and inter-cellular levels.  
These published observations and our own new experimental results have inspired us to 
look for all possible mechanisms for LPS priming and tolerance. To do this, we 
computationally searched the high-dimensional parameter space associated with a generic 
mathematical model of a three-node regulatory network. The search reveals only three 
mechanisms accounting for priming (pathway synergy, suppressor deactivation, activator 
induction) and one for tolerance (inhibitor persistence). Existing experimental results 
support these mechanisms.  
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In summary, our approach provides a systematic, quantitative framework for 
understanding numerous experimental observations, and it suggests new experimental 
procedures to identify the players and investigate the dynamics of priming and tolerance. 
Our analysis suggests that endotoxin tolerance and priming are rooted in the basic 
structure of the immune regulatory network: a signal often triggers synergizing pathways 
to ensure that sufficient responses can be elicited efficiently, as well as opposing 
pathways to ensure that the responses can be resolved eventually [2]. Therefore, in 
addition to shedding light on LPS-induced tolerance and priming, our approach is 
applicable in the more general context of cross-priming and cross-talk in the signal 
transduction mechanisms of the innate immune system [39-41]. 
Results 
 
Inducing priming and tolerance in a well-controlled experimental setting  
Although separate experimental studies of priming and tolerance have been carried out in 
many laboratories, no systematic study of both effects has been performed in the same 
setting. Thus, we first set out to measure priming and tolerance in the same experimental 
system. We used murine bone marrow derived macrophages (BMDM), which are widely 
used for measuring LPS responses. BMDM were treated with various combinations of 
LD (50 pg/mL) and HD (100 ng/mL) LPS for times indicated in Figure 1B. Cells were 
washed with PBS and fresh medium between consecutive treatments. Figure 1B shows 
that 50 pg/mL LPS induced negligible IL-6, while 100 ng/mL LPS induced robust 
expression of IL-6 in BMDM (~3300 fold). Consistent with previous findings, cells pre-
treated for 4 h with 50 pg/mL LPS exhibited ~4500 fold induction of IL-6 when 
challenged with 100 ng/mL LPS, a ~36% augmentation as compared to cells treated with 
100 ng/mL LPS alone (p < 0.05).  In contrast, cells pretreated for 4 h with 100 ng/mL 
LPS exhibited only ~700 fold induction of IL-6 when re-challenged with 100 ng/mL LPS, 
a ~80% reduction as compared to cells treated with 100 ng/mL LPS alone (p < 0.05).     
Identifying motifs that generate priming effect 
Figure 1C shows that LPS binding to TLR4 triggers two groups of parallel pathways: 
MyD88-dependent and (several) MyD88-independent pathways. Together, these 
pathways control the expression of different but overlapping inflammatory mediators in a 
delicate time-dependent and dose-dependent manner. Based on these parallel pathways, 
we proposed a three-node model in Figure 1C as a minimal abstraction of the system. 
Each node can positively or negatively regulate the activity of itself and the other two 
nodes. The interactions are governed, we assume, by a standardized set of nonlinear 
ordinary differential equations (Figure 1C) for xj = activity of the j
th
 node (0 ≤ xj ≤ 1, j = 
1,2,3). For a complete description of the mathematical model, see the section on 
Materials and Methods. The “network topology” of the model is determined by the sign 
pattern of the nine interaction coefficients (−1 ≤ ωji ≤ 1, j,i = 1,2,3) which express the 
magnitude and direction of the effect of node i on node j.  This is a coarse-grained model, 
with no distinction between intra- and inter-cellular events. For example, in a real cell the 
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self-regulation of a node may correspond to a feedback loop involving many 
intermediates, including extracellular cytokines. The simplicity of the model allows full 
search of the 14-dimensional parameter space (although there are 18 parameters in Table 
1, four of them are held constant, as explained in Materials and Methods). Similar three-
node models have been studied in other contexts [6,42,43]. 
We searched the 14-dimensional parameter space of the model for priming and then for 
tolerance. The behavior of the model is defined as “priming” if the maximum level of the 
output variable x3 under the priming dose (step 3 in Figure 1A) is small (x3 < 0.3), but 
with the subsequent high dose (step 4 in Figure 1A) x3 is at least 50% higher than the 
level reached without priming (step 1 in Figure 1A). Similarly, for “tolerance” the 
maximum level of x3 must be high enough under the first HD exposure (x3 > 0.3) but less 
intense by at least 50% under the second HD challenge (step 2 in Figure 1A). Precise 
criteria for priming and tolerance are provided in Table S1. Brute force search of the 
parameter space is impractical. Unbiased searching results in <1000 parameter sets 
exhibiting priming after 10
8
 Monte Carlo steps. Noticing that parameter sets giving 
priming or tolerance (called “good sets” for convenience) are clustered into a small 
number of isolated regions in parameter space, we designed a two-stage sampling 
procedure. First we perform a Metropolis search slightly biased for good sets. Next, to 
identify any isolated regions of parameter space where good sets are clustered, we 
analyzed the good sets using K-means clustering and Principal Component Analysis (see 
Text S1). The good sets then serve as seeds in the second stage of sampling, which 
restricts Metropolis searching to each local region of good sets. This two-stage procedure 
allows us to search the parameter space thoroughly and to obtain good-set samples that 
are large enough for statistical analysis. The overall procedure is illustrated schematically 
in Figure S1 and discussed in Text S1.  
Three basic mechanisms for the priming effect of LPS  
By trial-and-error, we found that the two experimentally measurable quantities, Δx1 and 
Δx2 (see Figure 2A), are effective in dividing the “good” parameter sets into three regions 
(see Figure 2B). Here Δx1 = maximum difference between x1 during the LD priming 
stage and the steady state value of x1 in the absence of any stimulus, and Δx2 = difference 
between the maximum values of x2 during the HD period with and without the priming 
pretreatment (Figure 2A). Further analysis (discussed below) revealed that the three 
groups correspond to three distinct priming mechanisms: “Pathway Synergy” (PS), 
“Activator Induction” (AI), and “Suppressor Deactivation” (SD). All AI and PS 
parameter sets show considerable increase in x2 (> 0.1) after the priming stage, while SD 
does not (Figure S2). 
To characterize these priming mechanisms, we next examined the parameter sets within 
each group for shared topological features. The topology of a regulatory motif is defined 
as the sign pattern (+, − or 0) of the nine interaction coefficients, ωji, with the proviso that 
ωji’s in the interval [−0.1, 0.1] are set = 0. We define a backbone motif as the simplest 
network topology that is shared by most of the good priming sets in each group and that 
is able to generate a priming effect on its own. Therefore, a backbone motif represents a 
core network structure in each group. Figure 3A shows that each group has its unique 
backbone motif(s), directly revealing different priming mechanisms in each group.  
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Figure S3 and Text S1 provide detailed statistical methods used to identify the backbone 
motifs. The two-dimensional parameter histograms in Figure S4 provide further support 
for the backbone motifs we have identified. 
Figure 3B-D shows typical time-courses and state-space trajectories for the three priming 
mechanisms (see Table S2 for the parameter values used to generate this figure). 
Pathway Synergy (PS): As shown in the upper left panel of Figure 3A, the backbone 
motif of PS mechanism contains both pathways through x1 and x2 activating x3. Under a 
single HD, the faster pathway through x1 prevents activation of x2, either directly or 
through x3. Consequently there is no synergy between the two pathways after a single 
HD. With LD pretreatment, however, x2 is partially activated. During the following HD 
treatment, this partial activation allows x2 to increase significantly, either transiently 
(Figure 3B left panel, called “monostable”) or persistently (Figure 3B right panel, called 
“bistable”), despite inhibition from x1 and/or x3. Simultaneous activation of both 
pathways leads to synergy between them and a priming effect for x3.  
Activator Induction (AI): In the backbone motif (see upper right panel of Figure 3A), the 
pathway through x1 (with high activation threshold) inhibits x3, whereas the pathway 
through x2 (with a low activation threshold) activates x3. Consequently, under a single 
HD, the two pathways work against each other to prevent full activation of x3. A LD 
pretreatment partially activates x2 without significantly affecting x1. Then, during the 
following HD treatment, x2 gets a head start on x1 to induce greater activation of x3 than 
observed under a single HD. The activation of x3 can be either transient (monostable) or 
persistent (bistable), as illustrated in Figure 3C and Figure S5A.  
Suppressor Deactivation (SD): In this case there are two backbone motifs slightly 
different from each other (the lower panel of Figure 3A). Both motifs contain an 
inhibition pathway (x1 ―| x3) with slow dynamics and low sensitivity to LPS, and an 
activation pathway (x2 → x3) with fast dynamics and high sensitivity to LPS. The basal 
level of the suppressor x1 is relatively high, which is typical of some suppressors (e.g. 
TOLLIP, TRAILR, PI3K and nuclear receptors) that are constitutively expressed in 
macrophages to prevent unwanted expression of downstream pro-inflammatory genes 
under non-stimulated conditions [44,45]. Compared to AI, in this case the LD 
pretreatment decreases the level of suppressor x1, through direct inhibition of x1 by x2. 
The basic SD effect is amplified either by x2 self-activation (backbone motif I) or by 
negative feedback from x3 to x1 (backbone motif II). As before, the activation of x3 can be 
either transient (monostable) or persistent (bistable), as illustrated in Figure 3B and 
Figure S5B. 
Combined backbone motifs may enhance the robustness of the priming effect 
Each of these groups contains many different network topologies (187 in PS, 139 in SD, 
and 82 in AI). Taking SD as an example, Figure 4A shows the sorted density distribution 
of the 139 unique topologies represented by the SD parameter sets. The top 7 of these 
topologies (Figure 4B) comprise 31% of all the SD parameter sets. Consistent with other 
studies [6,43], the most highly represented topologies contain more links than the 
corresponding backbone motif, indicating that additional links may increase the 
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robustness of a network. While the two backbone motifs rank Top 27 and Top 10 
respectively (Figure 4B), their combination ranks Top 4. The Venn diagram in Figure 4C 
shows that of the 93% of SD parameter sets that contain at least one of the two backbone 
motifs, 64% contain both. Notice that the two backbone motifs use different helpers to 
deactivate the suppressor (x1) under LD, the combination of motifs (Top 4) integrates 
both helpers so that deactivation of the suppressor can be enhanced (Figure 4C). The 
results of a similar analysis applied to PS and AI mechanisms are given in Figure S7.  
Additionally, in the Figure S8 and Text S1, we discuss a parameter compensation effect 
that further expands the priming region in the parameter space. 
Slow inhibitor relaxation dynamics is essential for the induction of tolerance 
We used the 3-node model to search for endotoxin-tolerance motifs. The tolerance effect 
requires that pro-inflammatory cytokine expression (x3) is markedly reduced (by at least 
1.5 fold) under two sequential HD treatments with LPS, compared to the level induced by 
a single HD (see Table S1 for details). Over 1660 unique topologies are found to give a 
tolerance effect (Figure 5A), indicating that the requirements for tolerance are much 
lower than for priming. A typical time course (Figure 5B, left panel) highlights the 
essential dynamical requirement for tolerance — to sustain a sufficiently high level of 
inhibitor (x1 in this case) after the first HD of LPS so that x3 is less responsive to the 
second HD stimulus. The effect is transient: if the second HD stimulus is delayed long 
enough for the suppressor to return to its basal level, then the tolerance effect is lost 
(Figure 5B, right panel). This “memory” effect has been noticed in other modeling 
studies [46-49] and is consistent with experimental observations. For example, the 
tolerance status of IL-6 is reported to persist for 48 h after the initial HD of LPS, but 
beyond this time a re-challenge started to recover the expression of IL-6 [34]. Figure 5C 
shows two backbone motifs that support temporary persistence of the inhibitor: by slow 
removal or by positive auto-regulation of the inhibitor. 
The dosing scenarios for priming and tolerance are well separated 
It is of interest to ask whether priming and tolerance can be observed in a single 3-node 
network given the corresponding dosing conditions. It turns out that about 11% of the 
priming motifs exhibit tolerance as well, and most of them belong to the SD or the AI 
mechanism. Figure 6A shows qualitatively the dose-response relationship for priming 
and tolerance in a typical network motif. First, both priming and tolerance require a 
relatively large second dose (>0.5). Second, the dosing regions for priming and tolerance 
are well separated. A low first dose (0.1−0.4) leads to priming while a higher one (0.5−1) 
leads to tolerance. There exists a range separating the priming and the tolerance region 
where neither are observed.  
Signaling durations affect the induction of priming and tolerance 
Most experimental studies of priming and tolerance are performed with fixed durations of 
the three time periods (T1, T2, and T3 in Figure 1A). Time-course measurements are 
rarely reported. The phase diagrams in Figure 6B & C show how varying each time 
period can affect the induction of priming and tolerance in a typical network motif. 
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Altogether, these results reveal important dynamical requirement in priming and 
tolerance and suggest systematic studies in real biological experiments. 
The left panel of Figure 6B shows the effects of varying stimulus durations (T1 and T3) at 
fixed gap duration (T2). To generate priming, T1 must be sufficiently long, while T3 can 
be relatively short (left panel of Figure 6B). A sufficient priming duration is crucial 
because the system utilizes this time to activate/deactivate the regulatory pathway with 
slower dynamics, i.e., the synergizing pathway in PS and the suppressor pathway in SD. 
Therefore, if T1 is too short, one may erroneously conclude that priming does not exist in 
the system. On the other hand, tolerance is less dependent on T1 (right panel of Figure 
6B). 
Figure 6C shows results when all durations are varied under the constraint T1 = T3. In this 
case, both priming and tolerance require that T2 is sufficiently short compared to the time 
required for the system to relax to its basal state after the first stimulus. This result 
reveals priming and tolerance as essentially the result of cellular memory of the first 
stimulation. 
Discussion  
 
Using a simple yet flexible model of cellular signaling pathways, we have carried out a 
systematic study of the topological and dynamic requirements for endotoxin priming and 
tolerance in cells of the innate immune system. Our study reveals that the phenomena of 
priming and tolerance can be attributed to a few characteristic network motifs (called 
“backbone” motifs) that are simple yet effective combinations of feed-forward loops, 
negative feedback signals, and auto-activation. In addition to reconciling the limited 
available experimental data on endotoxin priming and tolerance, our models suggest 
novel, testable hypotheses regarding the molecular mechanisms responsible for these 
effects.  
Essential modalities for priming and tolerance 
Our in silico analysis identifies three basic mechanisms for priming (Figure 7). In these 
mechanisms two pathways interact either constructively (pathway synergy−PS) or 
destructively (activator induction−AI, suppressor deactivation−SD). Compared to the 
response of these systems to a single high dose (HD) of LPS, a priming dose of LPS 
modifies the relative phases of the two pathways so as to strengthen pathway synergy (for 
PS mechanism) or weaken pathway interference (for SD and AI mechanisms).  
In this work we define the priming effect as a response of x3 that is at least 50% higher 
with priming than without. The threshold of 50% is consistent with experimental 
observations [23,25], but to be sure that our conclusions are robust, we also performed 
the computational analysis at two other thresholds: 30% augmentation or 70% 
augmentation (i.e., λ=1.3 or λ=1.7 in Table S1). In both cases we obtained results similar 
to those shown in Figure 2B, corresponding to the three priming mechanisms, although 
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the exact percentage of each priming mechanism among the data sets varies with the 
priming threshold. 
The priming effect may be viewed as a primitive counterpart of the more sophisticated 
memory mechanisms of the adaptive immune system. For a limited period of time after 
exposure to a weak stimulus, the system is prepared to launch a stronger response to a 
second exposure to the (same or another) stimulus [39,50]. On the other hand, tolerance 
reflects a transient refractory status to produce inflammatory cytokines due to the 
memory of an earlier exposure.  
Supporting experimental evidences at intra- and inter-cellular levels  
The actual molecular and cellular networks responsible for endotoxin priming and 
tolerance are highly complex, involving both intra- and inter-cellular signaling 
modalities. A combination of priming/tolerance motifs most likely coexist in real 
signaling networks, and their interactions will determine the specific properties of the 
priming/tolerance effect in vivo. LPS is known to activate multiple intracellular pathways 
through TLR4, including MyD88-dependent, TRIF-dependent pathways [51]. Cross-talk 
among these pathways may be differentially modulated by low vs. high dosages of LPS, 
and thus contribute to differential priming and tolerance [37,52,53].  
Endotoxin tolerance has drawn significant attention in the past due to its relevance to 
septic shock.  Existing literature reveals the involvement of multiple negative regulators 
(SHIP, ST2, IL-10, IRAK-M, SOCS1) at either intracellular or intercellular levels.  Many 
of them are shown to be persistently elevated during endotoxin tolerance, a key feature 
(confirmed by our systems analysis) creating a refractory state that suppresses the 
expression of pro-inflammatory mediators (see Table 2). For example, SHIP and ST2 are 
documented to have very slow degradation rates. On the other hand, negative regulators 
with faster turn-over rates, such as A20 and MKP1 (induced between 2−4 h by LPS), are 
known not to be required for LPS tolerance [21,54].  
In terms of priming, our in silico results are consistent with limited experimental data 
regarding potential molecular mechanisms. For example (Figure 8A), IL-12 and IL-10 
are differentially induced by low vs. high dose LPS, and subsequently serve as autocrine 
mediators to modulate LPS priming [19]. Figure 8B provides a second example. Low 
dose LPS (50 pg/mL) can selectively activate transcription factor C/EBPδ, yet fails to 
activate the classic NFκB pathway [53]. Hence, by a pathway synergy motif, the selective 
activation of C/EBPδ by low dose LPS may synergize with NFB under the subsequent 
high dose to induce the priming effect. While the removal of nuclear repressor by low 
dose LPS is reported [53], further evidence for the predicted suppressor deactivation 
mechanism awaits additional, targeted experimentation. In this context, one needs to be 
aware that our predicted network motifs are simple topologies that have the potential to 
generate priming or tolerance, within proper parameter ranges. Our predictions warrant 
further experimental studies to determine the physiologically relevant ranges of signaling 
parameters required for priming and tolerance.  
Our analysis of priming and tolerance is not limited to LPS. Bagchi et al. showed that 
cross-priming may happen between specific TLRs [41]. Ivashkiv and coworkers reported 
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that IFN-γ can prime macrophage for an augmented response to a variety of stimulants, 
including bacterial LPS, virus, IFN-α/β and IFN-γ itself [39,40]. IFN-γ self-priming is 
similar to LPS self-priming: a low dose can prime for boosted expression of interferon-
responsive genes. The priming mechanism as reported by Hu et al. resembles the AI 
strategy [55]. Interferon-responsive genes such as IRF1 and IP-10 are transcriptionally 
induced by transcription factor STAT1, and are inhibited by SOCS1 through a negative 
feedback mechanism. Low dose IFN-γ (1 U/ml) is able to elevate the expression level of 
STAT1, preparing macrophage for a boosted activation of STAT1 (through 
phosphorylation and dimerization of STAT1) under the high dose IFN-γ stimulation. 
With STAT1 being active, however, the inhibitor SOCS1 cannot be expressed during the 
priming stage, resulting in an augmented expression of IRF-1 and IP-10 (Figure 8C). 
Furthermore, Figure 8C suggests a possible cross-priming between IFN-γ and TLR4 via a 
PS mechanism. Priming of macrophage by a low dose IFN-γ promotes STAT1 
expression, which may synergistically cooperate with NFκB to give boosted cytokine 
expression to secondary stimulation by LPS [55,56]. Further experimental studies are 
needed to confirm the prediction.  
Limitations of three-node models and further theoretical studies 
Three-node models have been used to analyze functional network motifs in several 
contexts [6,7,43]. The simplicity of three-node models allows a thorough search of the 
parameter space. However, the model should be viewed as a minimal system. A typical 
biochemical network surely has more than three nodes. Therefore each node or link in the 
three-node model is normally coarse-grained from more complex networks. The model 
parameters are also composite quantities. Three-node models are limited in their ability to 
generate certain dynamic features such as time delays. Figure 3A shows the backbone 
motifs of the three mechanisms we have identified. Further studies of models with 
additional nodes will be necessary to determine whether all of the links are necessary.  
For example, in Figure 8B, we cannot find evidence for IL-6 inhibiting C/EBPδ (either 
by direct or indirect links). This lack of evidence may indicate a missing link waiting for 
experimental confirmation, or it may indicate a limitation of the three-node model. The 
parameter search algorithm developed in this work can be applied to models with 4 or 
more nodes, although the search space grows rapidly with the number of nodes.  
Despite the above-mentioned limitations, we expect that the three priming mechanisms 
and the one tolerance mechanism discovered here are quite general, holding beyond the 
three-node model. We expect that the present work can serve as a basis for analyzing 
larger networks with more mechanistic details. As illustrated in Figure 8, motifs can be 
combined together in series or in parallel, and these combined structures may lead to new 
dynamic properties of functional importance. 
Suggested experimental design 
Our analysis in Figure 6 suggests that systematic studies of signal durations (T1, T2 and 
T3) may reveal important details of the dynamics of priming and tolerance. For example, 
both relatively short (4 h, as the experiment in this paper) and longer priming duration (
≥ 20 h) are exhibit priming effects in macrophages [25]. Relatively fast transcriptional 
regulators like NFκB and AP-1, as well as numerous signaling repressors such as PI3K 
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and nuclear receptors, may be involved in intracellular priming motifs, inducing priming 
in response to short pretreatments. On the other hand, a longer pretreatment orchestrates 
more complex intercellular pathways whereby autocrine or paracrine signaling of 
cytokines (e.g. IL-10, IL-12 and type I IFNs) might dominate the induction of priming 
effects [19]. Therefore, measurements of the full time spectrum are necessary to reveal 
different parts of the network contributing to priming/tolerance.  
Furthermore, our analysis predicts that priming networks may respond in two distinct 
fashions: monostable (transient super-induction of cytokine) or bistable (sustained super-
induction of cytokines). Time-course measurements can distinguish between these two 
responses, keeping in mind that the bistable behavior predicted here is relative to the 
effective time-scale of the model. Each motif considered here is embedded in a larger 
network. Eventually, in a healthy organism pro-inflammatory cytokines have to be 
cleared out by some other slow processes that resolve the inflammation. On this longer 
time scale, the sustained induction of cytokines predicted by some of our models would 
be resolved. 
The analysis presented in Figure 2B suggests a plausible hypothesis to characterize 
underlying mechanisms of endotoxin priming. High throughput techniques can be used to 
identify genes and proteins that are significantly changed by low dose pretreatment. 
Likely candidates can be assayed during the course of a priming experiment, and the 
time-course data analyzed as in Figure 2B to identify the critical regulatory factors.  
Our analyses and simulations reveal that the priming effect is quite sensitive to system 
dynamics, i.e., to parameter values and initial conditions. It is well documented that many 
biological control systems, especially those involving gene expression, are stochastic in 
nature. Consequently a population of seemingly identical cells may respond 
heterogeneously to a fixed experimental protocol. In this case, single-cell measurements 
may reveal cell-to-cell variations in priming and tolerance responses [57-59]. 
Taken together, our integrated and systems analyses reconcile the intriguing paradigm of 
priming and tolerance in monocytes and macrophages. Given the significance and 
prevalence of this paradigm in immune cells to diverse stimulants other than LPS, our 
identified functional motifs will serve as potential guidance for future experimental 
works related to macrophage polarization as well as dynamic balance of immune 
homeostasis and pathogenesis of inflammatory diseases.   
Materials and Methods  
 
Mathematical description 
The following mathematical formalism is used to describe the dynamics of the three-node 
system, 
  
d
( ( ) )
d
j
j j j j
x
G W x
t
        
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where 
1
( )
1 a
G a
e


, and 
3
0 1j j ji i ji
W x S 

   . Notice that ( )jx t lies between 0 and 
1 for all t. All variables and parameters are dimensionless. ( )j jG W is a generic 
“sigmoidal” function with steepness (slope at Wj = 0) that increases with σj. Each ωji is a 
real number in [-1, 1] with its absolute value denoting the strength of the regulation; ωji > 
0 for the “activators” and ωji < 0 for “inhibitors” of node j. The sum, Wj, is the net 
activation or inhibition on node j, and ωj0 determines whether node j is “on” or “off” 
when all input signals are 0. The parameters γj determine how quickly each variable 
approaches its goal value, G(σjWj) for the present value of Wj. Because the magnitudes of 
the weights are bounded, |ωji| < 1, it is possible to do a thorough and systematic search of 
all possible weight matrices, even for networks of moderate complexity, e.g., K (= 
number of non-zero ωji’s) < 20. The formalism is close to that used by Vohradsky [60,61] 
and others [62,63] previously. More detailed discussions and applications of the 
formalism can be found in [64-66]. 
The model contains 18 parameters: 9 ωji’s, 3 γj’s, 3 σj’s and 3 ωj0’s. By setting 3 1  , we 
fix the time scale of the model to be the response time of the output variable, 3( )x t .  We 
set 30 0.50   , so that the response variable is close to 3 0x   in the absence of input. 
We also chose 3 6   as a moderate value for the sigmoidicity of the output response. 
Apart from that, 20  is set to be 0.25 so that the x2 pathway is responsive to LD 
stimulation. 
Monte Carlo sampling algorithm 
Our goal is to sample points in a 14-dimensional parameter space that is bounded and 
continuous. The sampling algorithm needs to search the parameter space thoroughly and 
generate sample parameter sets that are statistically unbiased and significant. Our strategy 
is a random walk based on the Metropolis Algorithm [67] through parameter space 
according to the following rules: 
0. Choose an initial parameter set 0θ  and determine its score: 0 0   if it is a 
“good” set, or 0 1   if it is not. (See Text S1 for the definition of a good set of 
parameters for priming or for tolerance.)   
1. Generate parameter set 1kθ  from kθ  by 1k k   θ θ ζ , where 0.025   
specifies the maximum displacement per step, and ζ  is a vector of random 
numbers with uniform distribution between -0.5 and 0.5.  
2. Compute 1k . If 1k k  , then accept the step from k to k+1. If 1k k  , 
then accept the step from k to k + 1 with probability ρ. Otherwise, reject the step k 
to k+1. 
3. Update k. If k is larger than a maximum step number, stop. Otherwise return to 
step 1.  
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We pursue this strategy in two stages. In stage 1, we set 0.0025   (see Text S1), so that 
the random walk has larger tendency to stay in “good” regions of parameter space, but 
can also jump out of a good region and searches randomly until it falls into another good 
region (which may be the same region it left). Stage 1 generates a random walk of 10
9
 
steps, which is sampled every 100 steps. From this sample of 10
7
 parameter sets only the 
good ones are saved, giving a sample of ~ 48 10  good parameter sets. These data are 
then analyzed as described below: 
1. The K-means algorithm is applied to identify possible clusters of good parameter 
sets in the 14-dimensional parameter space. The clustering result is then 
visualized through the first two principal components (which account for ~60% of 
the data variance) under Principal Component Analysis.  
2. One parameter set is chosen from each possible cluster to serve as starting points 
for stage 2. 
Stage 2 is a repeat of stage 1 with ρ = 0. In this case the random walk never leaves a good 
region. The purpose of stage 3 is to generate a large sample of good parameter sets that 
may occupy different regions of parameter space. The random walks are sampled every 
100 steps, generating 10
6
 good parameter sets from each starting point. Each parameter 
set must pass an additional test for “biological relevance” (see Text S1 for details) before 
further analysis.  
While the results reported in the main text are from one run of the search procedure, the 
whole procedure was repeated several times with random initial starting point in stage 1. 
The final results of these repeated runs agree with each other, confirming the 
convergence of our search procedure. 
Discretization of continuous parameter matrix into topology matrix 
In order to analyze the topological feature of each priming/tolerance mechanism, one 
needs to map the continuous parameters ωji into a discretized topological matrix τji. In the 
topological space, variables are only described by (−, 0, +) representing inhibition, no 
regulation and activation, respectively. A cut off value (= 0.1) is used to perform the 
discretization, following the rules below:  
 
1,    0.1
0,      0.1< 0.1
1,      0.1
ji
ji ji
ji
if
if
if

 

  

  


 
Experimental studies of LPS priming and tolerance 
Murine bone marrow derived macrophages from C57BL/6 wild type mice were harvested 
as described previously [53]. Cells were cultured in DMEM medium (Invitrogen) 
supplemented with 100 units/mL penicillin, 100 μg/mL streptomycin, 2 mM l-glutamine, 
and 10% fetal bovine serum (Hyclone) in a humidified incubator with 5% CO2 at 37 °C.  
Cells were treated with LPS (E. coli 0111:B4, Sigma) as indicated in the figure legend. 
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RNAs were harvested using Trizol reagent (Invitrogen) as previously described [53]. 
Quantitative real-time reverse-transcription (RT)-PCR were performed as described [68]. 
The relative levels of IL-6 message were calculated using the ΔΔCt method, using 
GAPDH as the internal control. The relative levels of mRNA from the untreated samples 
were adjusted to 1 and served as the basal control value.  
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Tables 
 
Table 1.  Description of modeling parameters.  
 
Parameter  Description 
xj Concentration (or activity) of species j 
γj Time scale of xj dynamics 
ωji Regulation strength of xi on xj 
ωj0 Activation threshold of xj 
σj Nonlinearity of the regulation relation associated to species xj 
Sj External signal strength acting on xj. (S3=0, S1=S2) 
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Table 2. Experimental evidence supporting the proposed tolerance mechanism. 
Molecular 
Candidate 
Inhibition Target Persistent 
Strategy 
Reported Evidence Reference 
IRAK-M IRAK-1 and 
IRAK-4 signaling 
Slow time scale Both mRNA and protein 
level of IRAK-M kept 
increased until 24 h with 
LPS stimulation. 
[31] 
SHIP NFκB pathway Slow time scale; 
Positive auto-
regulation of 
upstream 
regulator 
Slow but sustained 
production of SHIP 
(peaked at 24 h and 
remained high until 48 h 
with LPS stimulation), 
regulated via autocrine-
acting TGF-β; long half-
life of SHIP protein. 
[33] 
SOCS1  
(under 
debate) 
IRAK and NFκB 
pathway 
Slow time scale SOCS1 mRNA levels 
remains detectable 24 h 
post LPS stimulation. 
[69] 
ST2 MyD88 and Mal Slow time scale ST2 is induced at 4 h and 
lasts until 48 h with LPS 
stimulation. 
[32] 
IL-10 
(required but 
not necessary 
for tolerance) 
MyD88-dependent 
pathway (IRAK, 
TRAF6) 
Slow time scale; 
Positive 
autoregulation  
Significant level of IL-10 
was detected with 
prolonged (24 h) LPS 
stimulation, and the level 
is sustained until 48 h. The 
IL-10-activated STAT3 is 
required for efficient 
induction of IL-10. 
[35,70-72] 
DNA 
methylation 
and chromatin 
remodeling 
Proinflammatory 
cytokine (TNF-α) 
gene expression 
Slow time scale Sustained methylation of 
H3 (lys9), increased and 
sustained binding of RelB 
(as transcriptional 
repressor) on TNF-α 
promoter in tolerant THP-
1 cells. 
[36,73] 
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Figures 
 
 
Figure 1. Formulation of the problem. (A) Schematic illustration of in vitro experimental 
studies of LPS-induced tolerance and priming effect in macrophages. (B) IL-6 mRNA 
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levels of murine bone marrow derived macrophages treated with various combinations of 
LPS.  * p<0.05. (C) Abstraction of the parallel LPS associated pathways into a three-node 
network motif and the corresponding mathematical model based on ordinary differential 
equations. Refer to Materials and Methods for details. 
 
 
Figure 2. Three priming mechanisms revealed by time-course patterns. (A) Definition of 
clustering axis x1 and x2. x1 refers to the maximum difference between x1 during the 
LD priming stage and the steady state value of x1 in the absence of any stimulus. x2 
refers to the difference between the maximum values of x2 during the HD period with and 
without priming pretreatment. (B) The time courses of the priming data sets naturally 
divide into three clusters, corresponding to three priming mechanisms. The pie chart 
shows the relative frequencies of the priming mechanisms among all the priming 
parameter sets.  
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Figure 3. Details of the three priming mechanisms. (A) Backbone motifs (topological 
features shared by most of the good parameter sets) of each priming mechanism (see 
Figure S3 and Text S1 for details). The width of a line is proportional to the mean value 
of the corresponding ji among data sets under each priming mechanism. The “slow” and 
“fast” time scales reflect the values of γj in comparison to 3 = 1. (B-D) Typical time 
courses and corresponding phase space trajectories with or without LD pretreatment. 
Bistable results for AI and SD are shown in Figure S5.  
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Figure 4. Analysis of the robust priming topologies in the SD mechanism. (A) 139 
unique topologies under SD mechanism sorted by topology density (see Figure S6 and 
Text S1 for detailed discussion). (B) The highest seven density topologies and the 
backbone motifs. Line widths are proportional to the mean value of samples of the 
corresponding topology. Dashed lines denote the additional link present in the top 
topologies but absent in the backbone motif. (C) Combination of the two backbone motifs 
is common in the SD data sets. 93% of SD data sets are found to contain either Motif I or 
Motif II as the backbone motif. Among them, 64% contain both Motif I and Motif II. 
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Figure 5. Analysis of the tolerance data sets. (A) The unique topologies generating a 
tolerance effect sorted by topology density. (B) Typical time courses shown with normal 
(left panel) or elongated (right panel) gap period between the two doses. Solid line: time 
course tracking the dynamics of the system under the first HD stimulation, in gap period 
and under a second HD stimulation. Dashed line: time course tracking the dynamics 
under a single HD treatment; in this case the system is treated with no LPS during the 
otherwise first HD period. (C) Distribution of the change of x1 level due to the initial HD 
stimulation reveals two mechanisms to achieve slow relaxation dynamics in the inhibitor 
(left panel) and the corresponding two backbone motif (right panel).  
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Figure 6. Phase diagrams for priming and tolerance in a typical network motif. (A) 
Regions of dosing conditions for tolerance and priming are well separated. (B) Both 
priming and tolerance effects are affected by the duration of two sequential treatments 
(with the gap period between two doses being fixed). (C) Priming and tolerance are also 
affected by the duration of the gap between two doses. Very long gaps fail to exhibit 
either priming or tolerance.  
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Figure 7. Schematic illustration of constructive (PS) and destructive (AI, SD) pathway 
interference leading to priming effect. PS results from the activation of the LD-
responsive pathway (x2) which cooperates with the other HD-responsive pathway (x1) to 
boost cytokine expression in response to the following HD stimulus. AI results from 
activating a LD-responsive pathway (x2), which cancels the inhibition coming from the 
other HD-responsive inhibitor (x1) during the HD stage. SD results from deactivating a 
constitutively expressed suppressor (x1) during the priming stage. Red line with arrow 
head: activation pathway. Blue line with bar head: inhibition pathway. Line width 
denotes strength of the pathway controlling the downstream cytokine expression. 
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Figure 8. Example regulatory networks supporting the priming mechanisms. (A) The AI 
mechanism is consistent with observed intra- and inter-cellular molecular mechanisms for 
LPS priming, based on counterbalanced IL-10 and IL-12 signaling [19]. (B) The PS 
mechanism inspires this predicted intracellular molecular mechanism based on the 
selective activation of C/EBPδ by LD LPS. (C) IFN-γ self-priming and cross-priming to 
LPS follows the AI and PS mechanisms. Network details are retrieved from the database 
IPA (@Ingenuity) as well as the experimental literature listed in Table S3. Dashed lines 
refer to indirect regulations involving autocrine signaling loops. 
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Detailed criteria for priming and tolerance in the Metropolis searching algorithm  
We used the Metropolis algorithm [1] to search for parameter values for which the system 
exhibits priming or tolerance effects. Table S1 gives the criteria for identifying priming or 
tolerance parameter sets. In general, both priming and tolerance require the system to generate a 
dose-response curve having the following qualitative features: small signal (LD) gives small 
response and large signal (HD) gives large response; priming requires that LD+HD LPS gives a 
larger response than does a single HD LPS (positive control); tolerance requires that HD+HD 
LPS gives lower response than does a single HD LPS (positive control). Parameter sets that 
satisfy these conditions (either for priming or for tolerance) are called “good” sets. 
Two-stage Metropolis search for parameter sets that exhibit priming or tolerance 
It is impractical to perform a brute force search for priming/tolerance samples in a high 
dimensional parameter space. Figure S1A illustrates an alternative two-stage strategy. In the first 
stage, we searched widely over the parameter space with some bias to stay in a good parameter 
region and some chance to wander off in search of another good region. Then K-means 
Clustering and Principal Component Analysis was applied to the samples of good parameter sets 
generated in stage 1 to see if the data form several separate clusters. Each potential cluster 
provides a random seed for a second round of Metropolis searching. This time the search is 
restricted to stay within a good region, in order to search each region thoroughly and to obtain a 
representative sample of good parameter sets.  
To apply the Metropolis Algorithm, we relate the current problem of searching in the parameter 
space to sampling the partition function of a pseudo-statistical physics system. The bias 
controlling the probability of wandering out of a good region ( 10,   1k k    ) is defined by a 
Boltzmann-type expression 1
( )k ke
    where β represents an “inverse temperature” variable. 
There exists a trade-off value of β for the Metropolis search in stage I. If β is too large, the search 
will stay in a local minimum and fail to explore the parameter space thoroughly. If β is too small, 
the search cannot yield enough samples for the clustering analysis. Through trial and error, we 
found that β = 6 is a good value for the stage I Metropolis search, which gives ρ = 0.0025. Note 
that the priming region is very small compared to the whole parameter space. Therefore, 
although ρ = 0.0025 is very small, it still guarantees that the system has sufficient probability to 
leave the good regions and thoroughly search the parameter space. 
In the above procedure, the score function k plays the role of “energy” in a physical system. In 
general it can be a continuous function, and its gradient can guide the Metropolis search to the 
favorable region. For the current problem, the score function we use essentially behaves as a 
two-state system. Therefore we assign the value of k to be 0 or 1.  
We chose to use the Metropolis method for the first stage, but other methods will probably work 
equally well, e.g. genetic algorithm [2] and the methods used by Ma et al. [3] and Yao et al. [4]. 
Figure S1B provides the result of the two-stage Metropolis search. In the left panel the priming 
sets obtained from the first stage form three main clusters under the K-means Clustering. For 
visualization purpose the clusters in the high-dimensional parameter space are plotted using the 
first two components of Principal Component Analysis. Using the Khachiyan Algorithm [5], we 
calculated the minimal volume ellipsoid to embrace 99% of the parameter sets of each region. As 
shown in the right panel of Figure 1B which calculates the distance of a parameter set to the 
center of each bounding ellipsoid, it turns out that a single ellipsoid embraces clusters 1 and 2, 
thus forming one single region (we call it “Region I”). This result is independently confirmed 
with the following Metropolis simulation with ρ = 0: a trajectory starting from one cluster can 
generate parameter sets belonging to the other cluster. On the other hand, cluster 3 forms a 
separate region (Region II). Notice that a small portion of samples locate within both ellipsoids, 
indicating these two ellipsoids (regions) are barely connected. We found that Region II is 
actually (part of) the mirror image of Region I with the roles of x1 and x2 exchanged, reflecting 
the symmetry of the 3-node system. Therefore, the results discussed below and in the main text 
focus on the motifs found in Region I.  
About 10
6
 output samples are generated out of 10
8
 Metropolis steps in stage 2. Of these 10
6
 
samples, some appear to be biologically irrelevant and are removed from the sample set. For 
example, in some cases 3( )x t  
increases to a much higher level after the HD stimulation is 
removed, this would be a pathological response of the system. Other samples show 
unrealistically large sensitivity to initial conditions, i.e., although LD induced only small changes 
in x1, x2 and x3 (less than 10%), the system still exhibited priming effect. If priming were due to 
such small differences, then (in our opinion) the response would not be robust to the stochastic 
fluctuation expected in real systems [6-9]. 
While the results reported in the main text are from one trajectory result, the procedure was 
repeated several times with random initial start of the searching in stage 1. Results analyzed from 
different trajectories agree with each other, confirming the convergence of our two-stage 
Metropolis searching procedure.  
Statistical method used to identify backbone motifs 
A backbone motif is defined to be the simplest motif (the fewest number of non-zero ωji’s) that is 
shared by most of the priming/tolerance network structures in a particular region. A backbone 
motif must be able to generate a priming/tolerance effect by itself. Identification of backbone 
motifs helps to define the core mechanism of priming or tolerance. Figure S3 shows the 
statistical method used to obtain the backbone motifs for the pathway synergy group.  
Step 1: calculate the mean of each interaction coefficient ωji among all samples of the group, and 
map the mean values into a topological matrix τji (see Material and methods in the main text for 
the method of parameter discretization). 
Step 2: for each ωji calculate its coefficient of variation (CV = standard deviation divided by 
|mean|). The value of CV measures the dispersion of the data along each parameter dimension. A 
large value of CV suggests that a link is not essential and should not be part of the backbone 
motif. Only links with CV < CutOff should be part of a backbone motif. For CV > CutOff, τji = 0 
in the backbone motif.  
Step 2.1: determine the optimal value of CutOff. As CutOff decreases, the corresponding motif 
becomes simpler and therefore more samples contain this motif. However, the motif is a 
backbone motif only if it gives priming by itself. Therefore, there exists an optimal CutOff value 
so that the corresponding motif has the simplest topology that is still able to generate priming for 
some specific parameter sets. In this case the optimal CutOff = 0.54 (see the right figure in Step 
2.1 of Supplement Figure 3).  
Step 2.2: compare each dimension in the CV matrix to this optimal CutOff value, and obtain the 
corresponding backbone motif. 
Figure S4 shows 2D histograms of parameter distributions under each priming mechanism (PS, 
SD and AI). These histograms clearly highlight the corresponding backbone motifs. For example, 
for the 2D histogram shown in Supplemental Figure 4A, the PS data form clusters where both x1 
and x2 activate x3 (2
nd
 figure), and x3 feeds back negatively on x2 (4
th
 figure). Also x2 shows 
significant auto-activation but x1 does not (data spread out horizontally in the 5
th
 figure); this is 
in line with the backbone motif where x1 auto-regulation is not essential for priming. Similarly, 
x1 exerts strong inhibition on x2, whereas the regulation from x2 to x1 can be either negative, zero 
or positive (the 3
rd
 figure), in line with the backbone motif where this regulation is missing. In 
addition, the 1
st
 figure indicates that x1 should change on a much faster time-scale than x2. This is 
a dynamical requirement of pathway synergy in addition to the topological features as illustrated 
by the backbone motif. 
Motif density is more robust than frequency to variation in the topological cut-off 
To map from the continuous space of interaction coefficients ωji to the discrete space of network 
topologies τji, one must choose a cut-off value 0 for mapping ωji’s to −1, 0 or +1. We have 
chosen this cut-off 0 (somewhat arbitrarily) to be 0.1. The simplest way to order these 
topologies from “more robust” to “less robust” is in terms of the number of parameter sets that 
map into each topology, i.e., the frequency of each topology in the total data set. However, we 
find that topology-frequency is sensitive to the choice of the cut-off value for ωji. A better 
measure is topology density (Figure S6), defined as follows. The total volume of the 9-
dimensional space of interaction coefficients is 2
9
, because each ωji can continuously vary over 
[−1, 1]. For a motif with m non-zero τji’s, the volume of its subspace is 0(1 ) (0.9)
m m  .  The 
density of the motif is defined as the number of samples corresponding to this motif divided by 
the volume of its subspace. 
In Supplemental Figure 6 we compared the two ways of ordering the topologies using the SD 
data set as an example. The figure shows how the rank of robustness of each topology changes 
due to 10%, 30% and 50% positive or negative variations from the original cut-off 0 0.1  . A 
point on the figure with coordinate (x, y) means that the rank of a given topology is x with 
0 0.1  , but y with the varied 0 . Scattering from the diagonal indicates changing of the ranking 
due to 0 variation. The density-sorted rank (top panel) is less sensitive than the frequency-sorted 
one (lower panel) to the change of 0 . 
2D parameter correlations demonstrate how parameter compensation affects topological 
robustness 
We calculated the correlation matrix of each priming mechanism from the corresponding 
samples. As can be seen from Figure S8A, some parameters show strong anti-correlations. For a 
pair of anti-correlated parameters, increasing one can be compensated by decreasing the other (or 
negatively increasing the other if the regulation is inhibition), so the overall dynamics remains 
(approximately) the same. This is because in the modeling equations,  
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the activation of species xj is dependent on the overall net input Wj. As Wj sums inputs from all 
regulating nodes, a change in one parameter (e.g. ωj1) can be compensated by a change in a 
second parameter (e.g. ωj2) if the sum stays the same. Such parameter compensation expands the 
region of parameter space where priming or tolerance is observed and therefore affects the 
robustness of the model. 
For example, the left panel of Supplemental Figure 8B shows that the feedback from x3 to x2 
strongly anti-correlated with x2’s auto-regulation among SD datasets. With 23 = 0, the absolute 
value of 22 needs to be also small (the Null region in the right panel of Figure 8B), otherwise 
priming is abolished. However, since 23 and 22 are anti-correlated, the effect of an increasing 
22 can be canceled off by increasing ω23, thus expand the priming region in the parameter space 
(the upper left and bottom right regions of the right panel of Figure S8B). 
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Table S1. Criteria identifying priming and tolerance for a given parameter set x. 
A Good set of Single LD Single HD LD+HD HD+HD 
Priming RLD(x) < δLD RHD(x) ≥ δHD RLD+HD(x)/RHD(x) ≥ λ - 
Tolerance  RLD(x) < δLD RHD(x) ≥ δHD - RHD (x)/RHD+HD(x) ≥ λ 
Description LD signal 
stimulates 
small response. 
HD signal 
stimulates 
large 
response. 
Two sequential signals 
(LD followed by HD) 
gives a larger response 
than a single HD. 
Two sequential signals 
(HD followed by HD) 
gives a smaller response 
than a single HD. 
R denotes the maximum response of “cytokine” x3 under a specific stimulation protocol. LD: low 
dose; HD: high dose; LD+HD: LD followed by HD with maximum response measured in the 
HD period; HD+HD: HD followed by HD with maximum response measured in the second HD 
period. δLD and δHD denote the threshold of response under LD and HD, respectively. λ > 1 is the 
threshold of fold-change in the maximum response. The values we have chosen for these 
parameters (LD=0.1, HD=1, δLD=δHD=0.3, λ=1.5) are in qualitative agreement with experimental 
observations. 
 
Table S2. Parameter sets used to generate time course and phase-space trajectory in Figure 3 and 
Figure S5. 
 PS PS AI AI PS PS 
 bistable monostable bistable monostable bistable monostable 
ω11 0.26 0.19 -0.54 0 0.86 0.84 
ω12 -0.92 -0.27 0.05 -0.11 -0.78 -0.90 
ω13 0.61 0.23 -0.24 0.04 -0.86 -0.36 
ω21 -0.95 -0.93 -0.61 -0.52 0.36 0.08 
ω22 0.53 0.54 0.99 0.95 0.06 0.16 
ω23 -0.54 -0.35 -0.69 -0.89 -0.53 -0.45 
ω31 0.18 0.18 -0.80 -0.75 -0.96 -0.85 
ω32 0.47 0.27 0.83 0.82 0.89 0.93 
ω33 0.12 0.40 0.69 0.77 0.61 0.54 
γ1 1.56 0.43 0.10 0.11 0.14 0.15 
γ2 0.11 0.11 0.19 0.16 0.76 9.96 
γ3 1.00 1.00 1.00 1.00 1.00 1.00 
σ1 6.84 8.00 4.36 4.37 7.96 5.36 
σ2 7.19 8.00 6.55 6.89 6.33 5.50 
σ3 6.00 8.00 6.00 6.00 6.00 6.00 
ω10 -0.75 -0.50 -0.07 -0.22 -0.10 -0.15 
ω20 -0.25 -0.25 -0.25 -0.25 -0.25 -0.25 
ω30 -0.50 -0.50 -0.50 -0.50 -0.50 -0.50 
 
 
Table S3. Experimental literature supporting the network details in Figure 8.   
Figure 8  
Panel 
Source Target Regulatory Type Reference Comment 
A TLR4 IRAK Activation [1,2]  
A IRAK P38 Activation [3,4]  
A P38 IL-10 Transcription [5]  
A IL-10 IL-12 inhibition [6,7]  
A IL-10 TNFα inhibition [8,9]  
A IRAK AP-1 Activation [10]  
A AP-1 IL-12 Transcription [11,12]  
A IL-12 TNFα Transcription [9,13]  
A TNFα TNFα Positive auto-
regulation 
involving an 
autocrine loop 
[14]  
A IL-12 IL-12 Positive auto-
regulation 
involving an 
autocrine loop 
[15] IL-12 auto-regulates itself 
through Jak/Stat pathway 
with STAT4 being the major 
transcription factor. 
A TNFα IL-12 inhibition [16,17] TNFα inhibits IL-12p40 
through TNFα signaling 
pathway. 
B IRAK4 IKK Activation [2]  
B IKK NFκB Activation [2]  
B NFκB ATF3 Transcription [18]  
B ATF3 C/EBPδ Inhibition [19,20]  
B NFκB IL-6 Transcription [20]  
B IRAK1 IKKε Activation [21]  
B IKKε C/EBPδ Activation [21] Low dose LPS induces the 
expression of C/EBPδ 
through IRAK1 and IKKε.  
B C/EBPδ C/EBPδ Transcription [20] C/EBPδ can bind onto its own 
promoter to enhance the 
transcription. 
B C/EBPδ IL-6 Transcription [20]  
C IFNγ STAT1 Transcription [22] Low dose IFNγ elevates 
STAT1 transcription, but not 
STAT1 phosphorylation. 
C IFNγ P-STAT1 Activation [22] Phosphorylation of STAT1 is 
activated only under high 
dose IFNγ. 
C P-STAT1 SOCS1 Transcription [22]  
C SOCS1 P-STAT1 Inhibit [22] SOCS1 inhibits the 
phosphorylation and 
activation of STAT1. 
C P-STAT1 IRF-1, 
IP-10 
Transcription [22]  
C P-STAT1 TNFα Transcription [23] P-STAT1 may synergistically 
cooperate with NFκB to 
activate the transcription of 
TNFα. 
C TNFα SOCS1 Transcription [24] TNFα might be able to 
negatively feedback on P-
STAT1 through enhancing 
the production of SOCS1. 
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Figure S1. Illustration of the two-stage Metropolis search procedure. (A) Schematic 
illustration of the two-stage Metropolis search method for priming/tolerance parameter 
sets. In the first stage one randomly searches the whole parameter space. K-means 
clustering algorithm identifies one or more clusters of the data. Then one performs a 
second Metropolis step to search thoroughly inside each cluster. (B) As a result, we 
got three priming set clusters with K-means clustering. By calculating the minimum 
volume bounding ellipsoid, we found that cluster 1 and 2 belong to a single region 
(Region I) whereas cluster 3 belong to a separate region (Region II). 
Figure S2. Distribution of change in x2’s initial condition 
prior to HD without or without priming treatment. Both 
PS and AI show considerable increase in x2 in the primed 
system. PDF: probability distribution function.
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 Figure S3. Statistical method used to identify backbone motifs from priming/tolerance data.
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Figure S4. Parameter correlations highlight the backbone motifs of each priming mechanism. 
(A) Pathway Synergy, (B) Suppressor Deactivation, and (C) Activator Induction.
Figure S5. Typical time course and corresponding trajectory in the phase space. 
(A) bistable case of AI mechanism. (B) bistable case of SD mechanism. Refer to 
Figure 3 of the main text for the time course trajectories in other cases.
Figure S6. Change in the robustness rank as a result of variations in the topology cut-off. 
SD datasets are used as an example. The robustness rank is calculated based on density 
(top panel) or sample frequency (lower panel) of the unique topologies. Changes in the 
robustness rank is compared with 10% (left column), 30% (center column), and 50% 
(right column) variation in the topology cut-off τ0=0.1. 
Figure S7. Topologies of the PS and AI mechanisms. (A) The topology density distribution for 
the PS mechanism. (B) Top six PS topologies and the backbone motif. (C) The topology density 
distribution for the AI mechanism. (D) Top six AI topologies and the backbone motif. Line widths 
are proportional to the mean value of samples of the corresponding topology. Dashed lines denote 
the additional links present in the top topologies but absent in the backbone motif.
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Figure S8. Parameter correlation and compensation affects the robustness of the model. 
(A) Correlation matrix calculated based on the samples of each priming mechanism. 
The p-value is smaller than 0.05 except where marked. (B) The parameter compensation 
mechanism is illustrated by the 2D correlation histogram of the SD samples (left) and the 
corresponding connection diagrams (right).
